What FDA segments are included and excluded within the "NEW" Process Validation
How Stage 1 integrates with Phase 1
What are the Three Stages and Where Do They Apply within the NEW Process Validation
The Statutory and Regulatory Requirements for Process Validation
The Validation approaches that are included within this Guidance document
The Phase 1 Investigational Drug Requirements -- What is and What is NOT Required
An Introduction tPhase 1 Guidance for Industry and Its Application within the "NEW" Process Validation
Regulatory Strategies for Phase 2 and 3 and their Incorporation within Stages 1 and 2
General Considerations for Process Validation - Stage 2 Process Qualification
A Review of EU Annex 15 and its Comparison tFDA`s Process Validation Guidance
General Considerations for Process Validation - Stage 3 Continued Process Verification
Who should Attend
Project Management
Product Development
Quality Assurance
Regulatory Compliance
Manufacturing and Facilities professionals
Quality Control
Past Events
Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation) - 02-03 Mar 2020, Easton, Massachusetts, United States (67243)
Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation) 2019 - 06-07 May 2019, Residence Inn by Marriot Boston Cambridge, Massachusetts, United States (60559)
Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation) 2018 - 04-05 Oct 2018, Double Tree by Hilton Raleigh - Brownstone-University, North Carolina, United States (77024)
Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation) 2018 - 10-11 May 2018, Boston, Massachusetts, United States (67244)
Important
Please, check "Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)" official website for possible changes, before making any traveling arrangements